{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T02:53:40Z","timestamp":1783133620936,"version":"3.54.6"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.intimp.2025.114120","type":"journal-article","created":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T08:17:55Z","timestamp":1739002675000},"page":"114120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Activation of immune checkpoint OX40 inhibits HBV replication in a mouse model"],"prefix":"10.1016","volume":"149","author":[{"given":"Mengru","family":"Zhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoling","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqi","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8720-8463","authenticated-orcid":false,"given":"Xiuzhu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2025.114120_b0005","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/S0140-6736(14)60220-8","article-title":"Hepatitis B virus infection","volume":"384","author":"Tr\u00e9po","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2025.114120_b0010","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/qjmed\/hcr270","article-title":"Hepatitis B infection: current concepts and future challenges","volume":"105","author":"Nebbia","year":"2012","journal-title":"QJM"},{"key":"10.1016\/j.intimp.2025.114120_b0015","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0140-6736(09)60207-5","article-title":"Hepatitis B virus infection","volume":"373","author":"Liaw","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2025.114120_b0020","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1056\/NEJMra1810477","article-title":"Global Elimination of Chronic Hepatitis","volume":"380","author":"Thomas","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2025.114120_b0025","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/jvh.13040","article-title":"The impact of currently licensed therapies on viral and immune responses in chronic hepatitis B: Considerations for future novel therapeutics","volume":"26","author":"Gill","year":"2019","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.intimp.2025.114120_b0030","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1172\/JCI92812","article-title":"Hepatitis B virus-specific T cells associate with viral control upon nucleos(t)ide-analogue therapy discontinuation","volume":"128","author":"Rivino","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2025.114120_b0035","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/j.jhep.2016.01.026","article-title":"Adaptive immunity in HBV infection","volume":"64","author":"Bertoletti","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.intimp.2025.114120_b0040","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1172\/JCI120228","article-title":"T cell receptor grafting allows virological control of Hepatitis B virus infection","volume":"129","author":"Wisskirchen","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2025.114120_b0045","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/s41575-019-0196-9","article-title":"Restoring, releasing or replacing adaptive immunity in chronic hepatitis B","volume":"16","author":"Maini","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.intimp.2025.114120_b0050","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S2468-1253(18)30007-4","article-title":"Defective T-cell immunity in hepatitis B virus infection: why therapeutic vaccination needs a helping hand","volume":"3","author":"Maini","year":"2018","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.intimp.2025.114120_b0055","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.immuni.2016.04.022","article-title":"Costimulatory and Coinhibitory Receptor Pathways in Infectious Disease","volume":"44","author":"Attanasio","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2025.114120_b0060","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1146\/annurev-immunol-030409-101243","article-title":"Control of immunity by the TNFR-related molecule OX40 (CD134)","volume":"28","author":"Croft","year":"2010","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.intimp.2025.114120_b0065","doi-asserted-by":"crossref","first-page":"7240","DOI":"10.4049\/jimmunol.180.11.7240","article-title":"Activation of NF-kappaB1 by OX40 contributes to antigen-driven T cell expansion and survival","volume":"180","author":"Song","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2025.114120_b0070","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.4049\/jimmunol.175.6.3534","article-title":"OX40 and Bcl-xL promote the persistence of CD8 T cells to recall tumor-associated antigen","volume":"175","author":"Song","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2025.114120_b0075","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.jhep.2019.02.016","article-title":"OX40 stimulation and PD-L1 blockade synergistically augment HBV-specific CD4 T cells in patients with HBeAg-negative infection","volume":"70","author":"Jacobi","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.intimp.2025.114120_b0080","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aah5766","article-title":"An OX40\/OX40L interaction directs successful immunity to hepatitis B virus","volume":"10","author":"Publicover","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.intimp.2025.114120_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.107099","article-title":"Bifunctional macromolecule activating both OX40 and interferon-\u03b1 signaling displays potent therapeutic effects in mouse HBV and tumor models","volume":"89","author":"Mo","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2025.114120_b0090","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver. Electronic address eee European Association for the Study of the L (2017)EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol 67: 370-398. doi:10.1016\/j.jhep.2017.03.021.","DOI":"10.1016\/j.jhep.2017.03.021"},{"key":"10.1016\/j.intimp.2025.114120_b0095","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/imm.12400","article-title":"Amphiregulin promotes the immunosuppressive activity of intrahepatic CD4(+) regulatory T cells to impair CD8(+) T-cell immunity against hepatitis B virus infection","volume":"144","author":"Dai","year":"2015","journal-title":"Immunology"},{"key":"10.1016\/j.intimp.2025.114120_b0100","doi-asserted-by":"crossref","unstructured":"Crispe IN, Isolation of mouse intrahepatic lymphocytes. Curr Protoc Immunol Chapter 3: Unit 3.21, 2001. doi:10.1002\/0471142735.im0321s22.","DOI":"10.1002\/0471142735.im0321s22"},{"key":"10.1016\/j.intimp.2025.114120_b0105","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1073\/pnas.0913498107","article-title":"Immune effectors required for hepatitis B virus clearance","volume":"107","author":"Yang","year":"2010","journal-title":"PNAS"},{"key":"10.1016\/j.intimp.2025.114120_b0110","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/s41573-019-0037-0","article-title":"Therapeutic strategies for hepatitis B virus infection: towards a cure","volume":"18","author":"Fanning","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.intimp.2025.114120_b0115","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.4049\/jimmunol.176.4.2486","article-title":"OX40 ligation of CD4+ T cells enhances virus-specific CD8+ T cell memory responses independently of IL-2 and CD4+ T regulatory cell inhibition","volume":"176","author":"Yu","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2025.114120_b0120","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S1074-7613(00)80144-2","article-title":"OX40-deficient mice are defective in Th cell proliferation but are competent in generating B cell and CTL Responses after virus infection","volume":"11","author":"Kopf","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2025.114120_b0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002913","article-title":"OX40 facilitates control of a persistent virus infection","volume":"8","author":"Boettler","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.intimp.2025.114120_b0130","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/ni.2035","article-title":"T cell exhaustion","volume":"12","author":"Wherry","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2025.114120_b0135","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1084\/jem.20041395","article-title":"Age-related defects in CD4 T cell cognate helper function lead to reductions in humoral responses","volume":"200","author":"Eaton","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2025.114120_b0140","doi-asserted-by":"crossref","first-page":"6783","DOI":"10.4049\/jimmunol.0901296","article-title":"TLR-activated dendritic cells enhance the response of aged naive CD4 T cells via an IL-6-dependent mechanism","volume":"185","author":"Jones","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2025.114120_b0145","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1172\/JCI200316887","article-title":"Induction of immune tolerance to coagulation factor IX antigen by in vivo hepatic gene transfer","volume":"111","author":"Mingozzi","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2025.114120_b0150","doi-asserted-by":"crossref","unstructured":"Yang D, Liu L, Zhu D, Peng H, Su L, Fu YX Zhang L (2014) A mouse model for HBV immunotolerance and immunotherapy. Cell Mol Immunol 11: 71-78. doi:10.1038\/cmi.2013.43.","DOI":"10.1038\/cmi.2013.43"},{"key":"10.1016\/j.intimp.2025.114120_b0155","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.apsb.2019.08.010","article-title":"Therapeutic strategies for the costimulatory molecule OX40 in T-cell-mediated immunity","volume":"10","author":"Fu","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.intimp.2025.114120_b0160","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1128\/JVI.77.1.68-76.2003","article-title":"CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection","volume":"77","author":"Thimme","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.intimp.2025.114120_b0165","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/S0016-5085(99)70289-1","article-title":"Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection","volume":"117","author":"Maini","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.intimp.2025.114120_b0170","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1172\/JCI119498","article-title":"Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B","volume":"99","author":"Rossol","year":"1997","journal-title":"J. Clin. Invest."},{"issue":"56","key":"10.1016\/j.intimp.2025.114120_b0175","first-page":"10","article-title":"Polymorphisms of some cytokines and chronic hepatitis B and C virus infection","volume":"15","author":"Gao","year":"2009","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.intimp.2025.114120_b0180","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s12016-014-8465-4","article-title":"Cytokine-mediated immunopathogenesis of hepatitis B virus infections","volume":"50","author":"Li","year":"2016","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.intimp.2025.114120_b0185","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.coi.2015.06.016","article-title":"Host-virus interactions in hepatitis B virus infection","volume":"36","author":"Guidotti","year":"2015","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.intimp.2025.114120_b0190","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1146\/annurev.pathol.1.110304.100230","article-title":"Immunobiology and pathogenesis of viral hepatitis","volume":"1","author":"Guidotti","year":"2006","journal-title":"Annu. Rev. Pathol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925001092?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925001092?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:59:48Z","timestamp":1740617988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925001092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":38,"alternative-id":["S1567576925001092"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114120","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activation of immune checkpoint OX40 inhibits HBV replication in a mouse model","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114120","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114120"}}